Article Details

EC Approves Vabysmo for Two Leading Causes of Vision Loss - PharmTech

Retrieved on: 2022-09-27 16:27:56

Tags for this article:

Click the tags to see associated articles and topics

EC Approves Vabysmo for Two Leading Causes of Vision Loss - PharmTech. View article details on hiswai:

Excerpt

EC has approved Roche's Vabysmo, the first bispecific antibody for the eye, for two leading causes of vision loss.

Article found on: www.pharmtech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up